Correlation Between BioMark Diagnostics and Avricore Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioMark Diagnostics and Avricore Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioMark Diagnostics and Avricore Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioMark Diagnostics and Avricore Health, you can compare the effects of market volatilities on BioMark Diagnostics and Avricore Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioMark Diagnostics with a short position of Avricore Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioMark Diagnostics and Avricore Health.

Diversification Opportunities for BioMark Diagnostics and Avricore Health

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between BioMark and Avricore is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding BioMark Diagnostics and Avricore Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avricore Health and BioMark Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioMark Diagnostics are associated (or correlated) with Avricore Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avricore Health has no effect on the direction of BioMark Diagnostics i.e., BioMark Diagnostics and Avricore Health go up and down completely randomly.

Pair Corralation between BioMark Diagnostics and Avricore Health

Assuming the 90 days horizon BioMark Diagnostics is expected to generate 56.73 times less return on investment than Avricore Health. But when comparing it to its historical volatility, BioMark Diagnostics is 8.7 times less risky than Avricore Health. It trades about 0.01 of its potential returns per unit of risk. Avricore Health is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  6.38  in Avricore Health on September 13, 2024 and sell it today you would lose (0.19) from holding Avricore Health or give up 2.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

BioMark Diagnostics  vs.  Avricore Health

 Performance 
       Timeline  
BioMark Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioMark Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Avricore Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avricore Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

BioMark Diagnostics and Avricore Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioMark Diagnostics and Avricore Health

The main advantage of trading using opposite BioMark Diagnostics and Avricore Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioMark Diagnostics position performs unexpectedly, Avricore Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avricore Health will offset losses from the drop in Avricore Health's long position.
The idea behind BioMark Diagnostics and Avricore Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Global Correlations
Find global opportunities by holding instruments from different markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities